Wilson Martin 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Aug 20, 2025
Insider Transaction Report
Form 4
Wilson Martin
General Counsel
Transactions
- Sale
Common Stock
2025-08-18$3.06/sh−1,004$3,077→ 136,050 total - Sale
Common Stock
2025-08-19$3.00/sh−588$1,762→ 135,462 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.